Home/Filings/4/0001415889-24-019279
4//SEC Filing

Whiting Samuel 4

Accession 0001415889-24-019279

CIK 0001544227other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 7:35 PM ET

Size

5.0 KB

Accession

0001415889-24-019279

Insider Transaction Report

Form 4
Period: 2024-07-02
Whiting Samuel
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2024-07-02$2.13/sh+4,672$9,9519,573 total
Footnotes (1)
  • [F1]Includes 3,000 shares acquired under the Issuer's stock purchase plan.

Issuer

Tempest Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001870373

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 7:35 PM ET
Size
5.0 KB